Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.11%
SPX
+0.05%
IXIC
+0.02%
FTSE
+0.31%
N225
-0.04%
AXJO
-0.79%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
6.28M
Dividend Yield
0.00%
P/E Ratio
-0.40
EPS
-1.62
Revenue
-
Avg. Volume
31.81K

Recently from Cashu

publisher logo
Cashu

Indaptus Therapeutics Advances Cancer Therapy Pipeline with Innovative Immune-Based Treatments

6 days ago
publisher logo
Cashu

Indaptus Therapeutics: Request for Content Summary Not Provided

8 days ago
publisher logo
Cashu

Indaptus Therapeutics: Key Updates and Stock Insights

10 days ago

About

What does INDP do?
Indaptus Therapeutics, a preclinical biotechnology company based in New York City, focuses on multi-targeted immune system activation using a Decoy platform for anti-tumor and anti-viral responses. Its lead candidate, Decoy20, shows promise against chronic HBV and HIV infections.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Israel
Website
http://www.intecpharma.com
Stocks
Health Care
indp
Indaptus Therapeutics
INDP
-0.39 (-3.10%)
12.19
USD
At close at Jul 16, 14:39 UTC
Summary
News
Signals
Benchmarks
Financials